Location · Novi, MI
Clinical trials in Novi, MI
13 recruiting studies have a site in Novi, and 2 of them accept healthy volunteers.
13 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sanofi
- Location
- Novi, MI + 126 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Novi, MI + 131 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Novi, MI + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Alkermes, Inc.
- Location
- Novi, MI + 21 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Alkermes, Inc.
- Location
- Novi, MI + 21 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
AbbVie
- Location
- Novi, MI + 53 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Reunion Neuroscience Inc
- Location
- Novi, MI + 26 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Axsome Therapeutics, Inc.
- Location
- Novi, MI + 37 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Takeda
- Location
- Novi, MI + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Takeda
- Location
- Novi, MI + 18 other US sites
- Eligibility basics
- Ages 16–70
- RecruitingPhase 3
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Takeda
- Location
- Novi, MI + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
- Location
- Novi, MI + 44 other US sites
- Eligibility basics
- Ages 45–75
- RecruitingHealthy volunteers
The Use of Multiple Sensors to Track Sleep in Nightshift Workers
Henry Ford Health System
- Location
- Novi, MI
- Eligibility basics
- Ages 18+